These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1914341)

  • 1. Clinical pharmacokinetics in patients with liver disease.
    McLean AJ; Morgan DJ
    Clin Pharmacokinet; 1991 Jul; 21(1):42-69. PubMed ID: 1914341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
    Le Couteur DG; Fraser R; Hilmer S; Rivory LP; McLean AJ
    Clin Pharmacokinet; 2005; 44(2):187-200. PubMed ID: 15656697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.
    Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA
    Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatic microcirculation in the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Roy A; Lapointe R; Marleau D
    Hepatology; 1996 Jan; 23(1):24-31. PubMed ID: 8550044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.
    Le Couteur DG; McLean AJ
    Clin Pharmacokinet; 1998 May; 34(5):359-73. PubMed ID: 9592620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
    Verbeeck RK; Horsmans Y
    Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial perfusion decreases intrahepatic shunting and maintains glucose uptake in the rat liver.
    Alexander B; Rogers C; Naftalin R
    Pflugers Arch; 2002 May; 444(1-2):291-8. PubMed ID: 11976943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in liver disease.
    Breimer DD
    Pharm Weekbl Sci; 1987 Apr; 9(2):79-84. PubMed ID: 3295764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic disease and drug pharmacokinetics.
    Williams RL; Mamelok RD
    Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of liver cirrhosis on pharmacokinetics and pharmacodynamics of drugs].
    Perlík F
    Vnitr Lek; 2013 Jul; 59(7):584-6. PubMed ID: 23909263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
    Li P; Robertson TA; Zhang Q; Fletcher LM; Crawford DH; Weiss M; Roberts MS
    Pharm Res; 2012 Jun; 29(6):1658-69. PubMed ID: 22302523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of newer antibacterial agents in liver disease.
    Westphal JF; Brogard JM
    Clin Pharmacokinet; 1993 Jan; 24(1):46-58. PubMed ID: 8448972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug interactions in liver disease: An update.
    Palatini P; De Martin S
    World J Gastroenterol; 2016 Jan; 22(3):1260-78. PubMed ID: 26811663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic blood flow: morphologic aspects and physiologic regulation.
    Rappaport AM
    Int Rev Physiol; 1980; 21():1-63. PubMed ID: 6993392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.